Recombinant Human Anti-CD32B x Anti-Malaria Antigen Bispecific Antibody (Tandem Diabody) (T-BSDB-H287)

Recombinant Anti-CD32B x Anti-malaria antigen Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

CD32B & Malaria Antigen

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

CD32B

Gene ID

2213

UniProt ID

P31994

Alternative Names

FCGR2B; Fc fragment of IgG, low affinity IIb, receptor (CD32); FcγRIIB; CD32; FCG2; CD32B; FCGR2; IGFR2; low affinity immunoglobulin gamma Fc region receptor II-b; CDw32; fcRII-b; Fc gamma RIIb; fc-gamma-RIIb; fc-gamma RII-b; igG Fc receptor II-b; Fc fragment of IgG, low affinity II, receptor for (CD32); Fc fragment of IgG, low affinity IIb, receptor for (CD32)

Target 2

Malaria Antigen

Alternative Names

malaria antigen; parasitic protozoans

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "CD32B & Malaria Antigen"

See other bsAb targets related to "CD32B"

See other bsAb targets related to "Malaria Antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD32B x Anti-Malaria Antigen Bispecific Antibody (Tandem Diabody) (T-BSDB-H287). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD32B x Anti-Malaria Antigen Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-H287)

Specifications

Targets

Customer Reviews and Q&As